Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Celia Sourd

Celia Sourd


Postdoctoral Research Scientist

Celia’s background is in biochemistry and biotherapy, with a specific focus towards gene therapy. She completed her MSc in the University of Limoges (France) in 2018, gaining experience in CRISPR-based gene editing. She then did her PhD at Genethon (Evry, France) where she worked on the development of innovative gene therapy and gene editing strategies for a muscular gene disorder using Adeno-Associated Viruses (AAV) vectors.

Celia is now a member of Dr Kanmin Xue’s laboratory group, where her work will be focused on validating gene therapy strategies for Retinitis Pigmentosa diseases, as well as investigating immune responses against AAV vectors.


  • Kanmin Xue
    Kanmin Xue

    Wellcome Trust Clinical Research Career Development Fellow